- Home
- STHO vs NOTV Comparison
STHO vs NOTV Comparison
Compare STHO & NOTV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STHO
- NOTV
- Stock Information
- Founded
- STHO N/A
- NOTV 1974
- Country
- STHO United States
- NOTV United States
- Employees
- STHO N/A
- NOTV N/A
- Industry
- STHO Real Estate
- NOTV Biotechnology: Pharmaceutical Preparations
- Sector
- STHO Real Estate
- NOTV Health Care
- Exchange
- STHO Nasdaq
- NOTV Nasdaq
- Market Cap
- STHO 117.1M
- NOTV 137.5M
- IPO Year
- STHO N/A
- NOTV 1997
- Fundamental
- Price
- STHO $8.57
- NOTV $2.21
- Analyst Decision
- STHO
- NOTV Strong Buy
- Analyst Count
- STHO 0
- NOTV 3
- Target Price
- STHO N/A
- NOTV $5.92
- AVG Volume (30 Days)
- STHO 107.9K
- NOTV 552.5K
- Earning Date
- STHO 05-09-2025
- NOTV 05-09-2025
- Dividend Yield
- STHO N/A
- NOTV N/A
- EPS Growth
- STHO N/A
- NOTV N/A
- EPS
- STHO N/A
- NOTV N/A
- Revenue
- STHO $113,297,000.00
- NOTV $475,114,000.00
- Revenue This Year
- STHO N/A
- NOTV $6.37
- Revenue Next Year
- STHO N/A
- NOTV $5.74
- P/E Ratio
- STHO N/A
- NOTV N/A
- Revenue Growth
- STHO N/A
- NOTV N/A
- 52 Week Low
- STHO $7.96
- NOTV $1.23
- 52 Week High
- STHO $14.50
- NOTV $11.20
- Technical
- Relative Strength Index (RSI)
- STHO 51.53
- NOTV 35.56
- Support Level
- STHO $7.97
- NOTV $2.72
- Resistance Level
- STHO $8.42
- NOTV $3.35
- Average True Range (ATR)
- STHO 0.35
- NOTV 0.31
- MACD
- STHO 0.02
- NOTV -0.03
- Stochastic Oscillator
- STHO 53.10
- NOTV 16.79
About STHO Star Holdings Shares of Beneficial Interest
Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. It focuses on realizing value for shareholders from the legacy portfolio by maximizing cash flows through active asset management and asset sales.
About NOTV Inotiv Inc.
Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.